GeoVax CEO to Present Corporate Update at NobleCon21 Investor Conference
November 24, 2025 — GeoVax Labs CEO David Dodd presents corporate update at NobleCon21 investor conference. Learn about their COVID-19 vaccine trials, cancer immunotherapies & investment opportunities.